Feasibility and Psychometrics of an Ambulatory Hot Flash Monitoring Device
- 1 January 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Menopause
- Vol. 6 (3), 209-215
- https://doi.org/10.1097/00042192-199906030-00006
Abstract
To assess the feasibility and psychometric properties of a lightweight, automated, ambulatory sternal skin conductance monitor to measure frequency of hot Hashes (HFs) among breast cancer survivors (BCSs). A total of 19 postmenopausal BCSs and 5 premenopausal healthy comparison women participated by wearing the monitor for 24 h during their normal daily activities, including sleep. HFs were assessed using subjective (diaries, event markers) and objective (skin conductance) methods. Problems with subjective reporting of HFs were reported by 35% of BCSs. Technological problems and discomfort related to wearing the monitor were minimal. A total of 243 HFs were recorded using the skin conductance monitor by 17 BCSs and 5 premenopausal women (BCS group M = 13.4; range, 1-30). Subjective reporting of HFs was associated with a 31-33% false-positive rate. Skin conductance monitoring during waking hours was associated with a 30% false-negative rate. The monitor is a feasible method for objectively assessing HFs in BCSs. Data support continued use of sternal skin conductance as an objective measure of HF frequency. This technology should prove useful as an objective measure of HFs in future intervention research aimed at alleviating the symptom and improving quality of life among BCSs. (Menopause 1999;6:209-215. © 1999. The North American Menopause Society.)Keywords
This publication has 22 references indexed in Scilit:
- Treatment of Estrogen Deficiency Symptoms in Women Surviving Breast CancerJournal of Clinical Endocrinology & Metabolism, 1998
- Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.Journal of Clinical Oncology, 1998
- Alternatives to Estrogen for Menopausal WomenExperimental Biology and Medicine, 1998
- Hormone replacement therapy in cancer survivors: a con opinionCA: A Cancer Journal for Clinicians, 1996
- Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology GroupPublished by American Medical Association (AMA) ,1994
- Hot flashes: Phenomenology, quality of life, and search for treatment optionsExperimental Gerontology, 1994
- Transdermal clonidine for ameliorating tamoxifen-induced hot flashes.Journal of Clinical Oncology, 1994
- Hormone replacement therapy in previously treated breast cancer patientsThe American Journal of Surgery, 1993
- Hot Flashes: Epidemiology and PhysiologyaAnnals of the New York Academy of Sciences, 1990
- Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled studyMaturitas, 1987